These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 7568039)

  • 1. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
    J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
    Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
    Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Hafler DA
    Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
    Nag B; Arimilli S; Mukku PV; Astafieva I
    J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.
    Arimilli S; Mumm JB; Nag B
    Immunol Cell Biol; 1996 Feb; 74(1):96-104. PubMed ID: 8934660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
    Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
    J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
    Chou YK; Weinberg AD; Buenafe A; Bourdette DN; Whitham R; Kaleeba JA; Robey IF; Kavanagh DG; Offner H; Vandenbark AA
    J Neurosci Res; 1996 Sep; 45(6):838-51. PubMed ID: 8892096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.
    Boitel B; Ermonval M; Panina-Bordignon P; Mariuzza RA; Lanzavecchia A; Acuto O
    J Exp Med; 1992 Mar; 175(3):765-77. PubMed ID: 1371303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
    Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B
    J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anergy induction by dimeric TCR ligands.
    Appel H; Seth NP; Gauthier L; Wucherpfennig KW
    J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
    Wiertz E; van Gaans-van den Brink J; Hoogerhout P; Poolman J
    Eur J Immunol; 1993 Jan; 23(1):232-9. PubMed ID: 7678224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN; Chou YK; Whitham RH; Buckner J; Kwon HJ; Nepom GT; Buenafe A; Cooper SA; Allegretta M; Hashim GA; Offner H; Vandenbark AA
    J Immunol; 1998 Jul; 161(2):1034-44. PubMed ID: 9670985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of distinct peptide:I-Au conformers in murine experimental autoimmune encephalomyelitis.
    Huang JC; Han M; Minguela A; Pastor S; Qadri A; Ward ES
    J Immunol; 2003 Sep; 171(5):2467-77. PubMed ID: 12928395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited restriction in the TCR-alpha beta V region usage of antigen-specific clones. Recognition of myelin basic protein (amino acids 84-102) and Mycobacterium bovis 65-kDa heat shock protein (amino acids 3-13) by T cell clones established from peripheral blood mononuclear cells of monozygotic twins and HLA-identical individuals.
    Hawes GE; Struyk L; Godthelp BC; van den Elsen PJ
    J Immunol; 1995 Jan; 154(2):555-66. PubMed ID: 7529279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.